Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Longy

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Journal of Human Genetics|January 12, 2022
Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predispositionP Macquere, S Orazio, F Bonnet, et al.
Journal of Medical Genetics|May 24, 2001
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndromeG Bougeard, J M Limacher, C Martin, et al.
La Revue De Medecine Interne|August 16, 2000
[Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults]F Bonnet, P Morlat, D Neau, et al.
Cancer Research|May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisitedF Eisinger, J Jacquemier, C Charpin, et al.
American Journal of Medical Genetics|October 27, 1998
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le CancerL Essioux, C Girodet, O Sinilnikova, et al.
Genomics|February 13, 2001
High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1E Frengen, P Rocca-Serra, S Shaposhnikov, et al.
American Journal of Human Genetics|May 1, 1997
BRCA2 mutations in hereditary breast and ovarian cancer in FranceO M Serova-Sinilnikova, L Boutrand, D Stoppa-Lyonnet, et al.
La Revue De Medecine Interne|June 30, 2000
[Clinicobiological study of 100 symptomatic patients with factor V Leiden mutation]R Vatan, K Delpeu, C Vergnes, et al.
Arthritis and Rheumatism|January 7, 1998
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosisL Guillevin, J F Cordier, F Lhote, et al.
Genes, Chromosomes & Cancer|January 27, 1998
Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutationD J Marsh, P L Dahia, V Coulon, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Journal of Human Genetics|January 12, 2022
Increased incidence of pathogenic variants in ATM in the context of testing for breast and ovarian cancer predispositionP Macquere, S Orazio, F Bonnet, et al.
Journal of Medical Genetics|May 24, 2001
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndromeG Bougeard, J M Limacher, C Martin, et al.
La Revue De Medecine Interne|August 16, 2000
[Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults]F Bonnet, P Morlat, D Neau, et al.
Cancer Research|May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisitedF Eisinger, J Jacquemier, C Charpin, et al.
American Journal of Medical Genetics|October 27, 1998
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le CancerL Essioux, C Girodet, O Sinilnikova, et al.
Genomics|February 13, 2001
High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1E Frengen, P Rocca-Serra, S Shaposhnikov, et al.
American Journal of Human Genetics|May 1, 1997
BRCA2 mutations in hereditary breast and ovarian cancer in FranceO M Serova-Sinilnikova, L Boutrand, D Stoppa-Lyonnet, et al.
La Revue De Medecine Interne|June 30, 2000
[Clinicobiological study of 100 symptomatic patients with factor V Leiden mutation]R Vatan, K Delpeu, C Vergnes, et al.
Arthritis and Rheumatism|January 7, 1998
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosisL Guillevin, J F Cordier, F Lhote, et al.
Genes, Chromosomes & Cancer|January 27, 1998
Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutationD J Marsh, P L Dahia, V Coulon, et al.
Pageof 18